Deva Holding A.S.
Pharmaceutical manufacturer Deva Holding A.S. is a Turkish Fortune 500 company with annual revenue of more than US$250 million and a staff of approximately 2,300 across its operations in Turkey, Germany, USA and New Zealand.[1][2][3]
| Pharmaceutical Company | |
| Traded as | BİST: DEVA |
| Industry | Healthcare |
| Founded | September 22, 1958 |
| Headquarters | Istanbul, Turkey |
Key people | Mr. Philipp Haas (Chairman and CEO) |
| Products | Pharmaceuticals |
| Revenue | US$250M |
Number of employees | 2,300 |
| Website | www.deva.com.tr |
Background
Established in 1958, Deva Holding A.S. is Turkey’s second largest pharmaceutical company and is primarily engaged in the production and distribution of pharmaceutical and veterinary products.[4][5]
gollark: If only I actually got that xenowyrm yesterday.
gollark: So someone probably has one and offered.
gollark: Indeed.
gollark: I accidentally somehow copied my cheese trade or something. I don't know how.
gollark: https://dragcave.net/teleport/1410efa5b0825595c9cf8a11219c51fe
References
- "Antibiotic Long Distance Run". Fortune Magazine. 19 July 2019. Retrieved 15 September 2019.
- "5 Minutes Interview with: Philipp Haas - Deva". Pharma Horizon Magazine. 4 May 2017. Retrieved 15 September 2019.
- "Philipp Haas – Chairman & CEO, DEVA, Turkey". Pharma Boardroom Magazine. 29 November 2018. Retrieved 15 September 2019.
- "» 5 minutes interview with: Philipp Haas – DEVA". TKS Publisher. Retrieved 2019-10-28.
- "DEVA.IS - Deva Holding AS Profile | Reuters". www.reuters.com. Retrieved 2019-10-28.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.